Background/aims: Allopregnanolone suppresses central nervous system activity and has neuroprotective actions in hypoxia-induced brain injury. In pregnant sheep allopregnanolone concentrations are high during fetal life and decline rapidly after birth. We investigated brain allopregnanolone concentrations of fetal and postnatal rats derived from normal and growth restricted pregnancies.

Methods: Bilateral uterine vessel ligation (or sham) was performed at gestation day 18 to induce uteroplacental insufficiency in WKY rats (n = 7-8 per group). Brain allopregnanolone was measured by radioimmunoassay at 2 study ages, gestation day 20 (n = 6 per group) and postnatal day 6 (n = 6-8 per group), from control and growth-restricted pups.

Results: Fetal brain allopregnanolone concentrations were higher in growth-restricted fetuses compared to control (p < 0.05). Allopregnanolone concentrations decreased at birth with a greater decline in growth restriction (p < 0.05). Postnatal day 6 brain allopregnanolone concentrations were lower in growth restriction (p < 0.05).

Conclusions: Growth restriction is a potent stimulus for neurosteroid synthesis in the fetal brain in late pregnancy. The low concentrations of allopregnanolone in the growth-restricted postnatal brain suggest a delay in the capacity of the adrenal gland or brain to synthesize pregnane steroids or their precursors and may render the postnatal brain vulnerable to hypoxia-induced injury.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000139771DOI Listing

Publication Analysis

Top Keywords

brain allopregnanolone
20
allopregnanolone concentrations
20
growth restriction
12
brain
10
fetal postnatal
8
uteroplacental insufficiency
8
allopregnanolone
8
gestation day
8
postnatal day
8
fetal brain
8

Similar Publications

Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells.

Neuropharmacology

January 2025

Dept. of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, Catania, Italy. Electronic address:

The central nervous system is a well-known steroidogenic tissue producing, among others, cholesterol metabolites such as neuroactive steroids, oxysterols and steroid hormones. It is well known that these endogenous molecules affect several receptor classes, including ionotropic GABAergic and NMDA glutamatergic receptors in neurons. It has been shown that also ionotropic purinergic (P2X) receptors are cholesterol metabolites' targets.

View Article and Find Full Text PDF

Neurotoxic effects of citronellol induced by the conversion of kynurenine to 3-hydroxykynurenine.

J Hazard Mater

December 2024

Zebrafish Translational Medical Research Center, Korea University, Ansan, Gyeonggi-do, Republic of Korea; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea. Electronic address:

Citronellol is widely utilized in consumer products, including cosmetics, fragrances, and household items. However, despite being considered a relatively safe chemical, the health effects and toxicity mechanisms associated with exposure to high concentrations of citronellol, based on product content, remain inadequately understood. Here, we aimed to analyze the neurological effects of citronellol in zebrafish larvae using behavioral and histological analyses and elucidate the mechanisms underlying its neurotoxicity in vivo.

View Article and Find Full Text PDF

Panic disorder is more frequent in women than in men. In women, vulnerability to panic is enhanced during the late luteal phase of the menstrual cycle. At this time secretion of progesterone and its neuroactive metabolite allopregnanolone (ALLO), which acts as a positive allosteric modulator of the actions of GABA at GABA receptors, decline sharply.

View Article and Find Full Text PDF

Neurosteroid replacement approaches for improving outcomes after compromised pregnancies and preterm birth.

Front Neuroendocrinol

November 2024

School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia; Hunter Medical Research Institute, Mothers and Babies Research Program, Newcastle, Australia.

Article Synopsis
  • High levels of the neurosteroid allopregnanolone during pregnancy are crucial for fetal brain development, but maternal stress can lower these levels, leading to myelination issues and increased behavioral disorders in childhood.
  • Supplementing neurosteroid action with allopregnanolone analogues or using mitochondrial translocator protein (TSPO) ligands can help reverse developmental deficits that arise from low allopregnanolone levels.
  • Preterm birth significantly decreases neurosteroid support, causing severe myelination deficits; however, postnatal treatments like ganaxolone can enhance myelination and reduce hyperactivity, suggesting potential therapeutic benefits of allopregnanolone after pregnancy issues.
View Article and Find Full Text PDF

The endogenous neurosteroid (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP) modulates inflammatory and neuroinflammatory signaling through toll-like receptors (TLRs) in human and mouse macrophages, human blood cells and alcohol-preferring (P) rat brains. Although it is recognized that 3α,5α-THP inhibits TLR4 activation by blocking interactions with MD2 and MyD88, the comprehensive molecular mechanisms remain to be elucidated. This study explores additional TLR4 activation sites, including TIRAP binding to MyD88, which is pivotal for MyD88 myddosome formation, as well as LPS interactions with the TLR4:MD2 complex.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!